Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1931 1
1933 1
1934 1
1938 1
1946 2
1948 2
1951 2
1953 1
1955 1
1956 3
1958 2
1959 1
1961 1
1962 2
1963 3
1964 1
1965 10
1966 2
1967 6
1968 12
1969 8
1970 4
1971 2
1972 3
1973 3
1974 3
1975 3
1976 1
1977 3
1978 2
1979 1
1982 3
1983 8
1984 6
1985 11
1986 15
1987 8
1988 9
1989 11
1990 6
1991 12
1992 16
1993 21
1994 19
1995 17
1996 20
1997 13
1998 15
1999 21
2000 18
2001 26
2002 20
2003 22
2004 27
2005 36
2006 38
2007 35
2008 38
2009 59
2010 48
2011 57
2012 56
2013 55
2014 94
2015 80
2016 81
2017 81
2018 87
2019 84
2020 96
2021 117
2022 91
2023 103
2024 104
2025 123
2026 19

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,805 results

Results by year

Filters applied: . Clear all
Page 1
Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma.
Hassel JC, Piperno-Neumann S, Rutkowski P, Baurain JF, Schlaak M, Butler MO, Sullivan RJ, Dummer R, Kirkwood JM, Orloff M, Sacco JJ, Ochsenreither S, Joshua AM, Gastaud L, Curti B, Piulats JM, Salama AKS, Shoushtari AN, Demidov L, Milhem M, Chmielowski B, Kim KB, Carvajal RD, Hamid O, Collins L, Ranade K, Holland C, Pfeiffer C, Nathan P. Hassel JC, et al. Among authors: collins l. N Engl J Med. 2023 Dec 14;389(24):2256-2266. doi: 10.1056/NEJMoa2304753. Epub 2023 Oct 21. N Engl J Med. 2023. PMID: 37870955 Free PMC article. Clinical Trial.
Glucagon-Like Peptide-1 Receptor Agonists.
Collins L, Costello RA. Collins L, et al. 2024 Feb 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Feb 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 31855395 Free Books & Documents.
Classification of Fibroepithelial Lesions of the Breast in Core Needle Biopsy With Implications for Further Management.
Rakha EA, Quinn C, Raymond W, Allison KH, Badve SS, Brogi E, Callagy G, Charafe-Jauffret E, Chen CJ, Chen YY, Collins LC, Cserni G, Djerroudi L, Jaffer S, Foschini MP, Gobbi H, Gudi M, Harada O, Kulka J, Kuroda H, Lakhani SR, Li X, Moriya T, O'Toole SA, Pinder SE, Provenzano E, Sahin AA, Schmitt F, Shaaban AM, Siziopikou KP, Tang P, Tse GM, Varga Z, Vincent-Salomon A, Wen H, Yamaguchi R, Yang W, Fox SB, Schnitt SJ, Ellis IO, Tan PH. Rakha EA, et al. Among authors: collins lc. Mod Pathol. 2025 May;38(5):100734. doi: 10.1016/j.modpat.2025.100734. Epub 2025 Feb 11. Mod Pathol. 2025. PMID: 39947480 Free article. Review.
Clinical and molecular response to tebentafusp in previously treated patients with metastatic uveal melanoma: a phase 2 trial.
Carvajal RD, Butler MO, Shoushtari AN, Hassel JC, Ikeguchi A, Hernandez-Aya L, Nathan P, Hamid O, Piulats JM, Rioth M, Johnson DB, Luke JJ, Espinosa E, Leyvraz S, Collins L, Goodall HM, Ranade K, Holland C, Abdullah SE, Sacco JJ, Sato T. Carvajal RD, et al. Among authors: collins l. Nat Med. 2022 Nov;28(11):2364-2373. doi: 10.1038/s41591-022-02015-7. Epub 2022 Oct 13. Nat Med. 2022. PMID: 36229663 Free PMC article. Clinical Trial.
Ivermectin to Control Malaria - A Cluster-Randomized Trial.
Chaccour C, Maia M, Kariuki M, Ruiz-Castillo P, Wanjiku C, Kasiwa L, Brazeal A, Casellas A, Ngama M, Onyango T, Elobolobo E, Kazungu K, Mael M, Wangari W, Nuru K, Otuko R, Sanz A, Ringera I, Matano A, Mitora S, Ribes M, Brew J, Gorski N, Nicolas P, Stanulovic S, Omondi I, Furnival-Adams J, Túnez L, Mbarak J, Vegove V, Yaa E, Mramba S, Kibet Y, Nyambura N, Rotich C, Wanjiru S, Vura M, Wanjiku F, Sam L, Collins L, Xia K, Hammann F, Saúte F, Rudd M, Rist C, Jones C, Mwangangi J, Rabinovich NR. Chaccour C, et al. Among authors: collins l. N Engl J Med. 2025 Jul 24;393(4):362-375. doi: 10.1056/NEJMoa2411262. N Engl J Med. 2025. PMID: 40700688 Clinical Trial.
Spindle Cell Lesions.
Guzmán-Arocho YD, Collins LC. Guzmán-Arocho YD, et al. Among authors: collins lc. Surg Pathol Clin. 2025 Dec;18(4):639-650. doi: 10.1016/j.path.2025.05.002. Epub 2025 Jul 2. Surg Pathol Clin. 2025. PMID: 41224409 Review.
A SETD2-CDK1-lamin axis maintains nuclear morphology and genome stability.
Khan A, Zhang C, Nguyen PG, Metts JM, Collins LC, Jain K, Mills CA, Vlach L, Li K, Brademeyer AL, Bowman BM, Major MB, Aubé J, Herring LE, Rathmell WK, Mason FM, Davis IJ, Zhang Q, Strahl BD. Khan A, et al. Among authors: collins lc. Nat Cell Biol. 2025 Aug;27(8):1327-1341. doi: 10.1038/s41556-025-01723-9. Epub 2025 Aug 11. Nat Cell Biol. 2025. PMID: 40789955
Beyond mandates.
Collins LR. Collins LR. F S Rep. 2022 Nov 12;3(4):296-297. doi: 10.1016/j.xfre.2022.11.003. eCollection 2022 Dec. F S Rep. 2022. PMID: 36568930 Free PMC article. No abstract available.
Malignant phyllodes tumours of the breast: the case for revising WHO's 'full house' diagnostic criteria.
Tan PH, Ellis IO, Allison KH, Badve SS, Brogi E, Callagy G, Charafe-Jauffret E, Chen CJ, Chen YY, Collins LC, Cserni G, Djerroudi L, Foschini MP, Fox SB, Gobbi H, Gudi M, Harada O, Jaffer S, Kulka J, Kuroda H, Lakhani SR, Li X, Moriya T, O'Toole S, Pinder SE, Provenzano E, Quinn C, Raymond W, Sahin AA, Schmitt F, Shaaban AM, Shet T, Siziopikou KP, Tang P, Tse GM, Varga Z, Vincent-Salomon A, Wen H, Yamaguchi R, Yang W, Schnitt SJ, Rakha EA. Tan PH, et al. Among authors: collins lc. Histopathology. 2025 Aug;87(2):169-182. doi: 10.1111/his.15455. Epub 2025 Apr 13. Histopathology. 2025. PMID: 40223225 Free PMC article. Review.
Evolution of the tumor immune landscape during treatment with tebentafusp, a T cell receptor-CD3 bispecific.
Sacco JJ, Kirk P, Leach E, Shoushtari AN, Carvajal RD, Britton-Rivet C, Khakoo S, Collins L, de la Cruz-Merino L, Eroglu Z, Ikeguchi AP, Nathan P, Hamid O, Butler MO, Stanhope S, Ranade K, Sato T. Sacco JJ, et al. Among authors: collins l. Cell Rep Med. 2025 Apr 15;6(4):102076. doi: 10.1016/j.xcrm.2025.102076. Cell Rep Med. 2025. PMID: 40239619 Free PMC article. Clinical Trial.
1,805 results